Pacific Biosciences of California Inc (PACB)
1.465
+0.06
(+4.64%)
USD |
NASDAQ |
Apr 18, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Total Liabilities (Quarterly): 1.045B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.045B |
| September 30, 2023 | 1.135B |
| June 30, 2023 | 1.206B |
| March 31, 2023 | 1.204B |
| December 31, 2022 | 1.204B |
| September 30, 2022 | 1.192B |
| June 30, 2022 | 1.194B |
| March 31, 2022 | 1.202B |
| December 31, 2021 | 1.216B |
| September 30, 2021 | 1.193B |
| June 30, 2021 | 987.54M |
| March 31, 2021 | 972.34M |
| December 31, 2020 | 78.49M |
| September 30, 2020 | 170.82M |
| June 30, 2020 | 172.26M |
| March 31, 2020 | 174.36M |
| December 31, 2019 | 93.07M |
| September 30, 2019 | 95.10M |
| June 30, 2019 | 94.83M |
| March 31, 2019 | 90.73M |
| December 31, 2018 | 56.21M |
| September 30, 2018 | 51.03M |
| June 30, 2018 | 51.58M |
| March 31, 2018 | 54.21M |
| December 31, 2017 | 57.98M |
| Date | Value |
|---|---|
| September 30, 2017 | 56.50M |
| June 30, 2017 | 62.04M |
| March 31, 2017 | 66.32M |
| December 31, 2016 | 53.22M |
| September 30, 2016 | 51.96M |
| June 30, 2016 | 53.30M |
| March 31, 2016 | 51.40M |
| December 31, 2015 | 57.57M |
| September 30, 2015 | 58.41M |
| June 30, 2015 | 62.93M |
| March 31, 2015 | 65.95M |
| December 31, 2014 | 69.44M |
| September 30, 2014 | 68.61M |
| June 30, 2014 | 69.23M |
| March 31, 2014 | 65.52M |
| December 31, 2013 | 67.00M |
| September 30, 2013 | 69.26M |
| June 30, 2013 | 33.88M |
| March 31, 2013 | 32.68M |
| December 31, 2012 | 20.30M |
| September 30, 2012 | 19.67M |
| June 30, 2012 | 21.73M |
| March 31, 2012 | 26.84M |
| December 31, 2011 | 26.85M |
| September 30, 2011 | 27.28M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
78.49M
Minimum
Dec 2020
1.216B
Maximum
Dec 2021
770.01M
Average
1.045B
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Integer Holdings Corp | 1.424B |
| Cerus Corp | 144.30M |
| Axogen Inc | 101.16M |
| AVITA Medical Inc | 62.58M |
| Intellia Therapeutics Inc | 250.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.746B |
| Shareholders Equity (Quarterly) | 701.30M |
| Debt to Equity Ratio | 1.273 |
| Current Ratio | 7.809 |
| Net Debt Paydown Yield | 0.03% |